|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148.50 GBX | +0.34% |
|
+4.21% | +16.02% |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 05-26 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 5 | |||||||
| 14 | |||||||
| 5 | |||||||
| 4 | |||||||
| 19 | |||||||
| 2 | |||||||
| 3 | |||||||
| - | 1 | ||||||
| 10 | |||||||
| 6 | |||||||
| 3 | |||||||
| 2 | |||||||
| 2 | |||||||
| Average | 6 | |||||||
| Weighted average by Cap. | 13 |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
